Saudi Arabia vs Upper-middle income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc)
Saudi Arabia
98.0%
in 2025
Upper-middle income (World Bank)
49.0%
in 2025
Saudi Arabia rank
11th
Upper-middle income (World Bank) rank
10th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Saudi Arabia
- Upper-middle income (World Bank)
How they compare
Saudi Arabia currently reports 98.0% against 49.0% in Upper-middle income (World Bank), a difference of 49.0%.
That makes Saudi Arabia's figure about 2.0 times Upper-middle income (World Bank)'s.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Upper-middle income (World Bank) ahead.
Saudi Arabia ranks 11th and Upper-middle income (World Bank) ranks 10th of 194 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Upper-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.0% | 3.0% | 46.0% | Saudi Arabia |
| 2010s | 97.8% | 22.9% | 74.9% | Saudi Arabia |
| 2020s | 96.8% | 38.8% | 58.0% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Saudi Arabia or Upper-middle income (World Bank)?
- Saudi Arabia, at 98.0% against 49.0% in Upper-middle income (World Bank) as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Saudi Arabia and Upper-middle income (World Bank)?
- 49.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Upper-middle income (World Bank)?
- 18 years are reported by both, from 2008 to 2025.
- How do Saudi Arabia and Upper-middle income (World Bank) rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Saudi Arabia ranks 11th and Upper-middle income (World Bank) ranks 10th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.